Parmar, Krupa
Chaudhry, Waqas
Fackler, Joseph R.
Sowers, John M.
Vadlamudi, Aravinda
Greenwood-Quaintance, Kerryl
Patel, Robin
Article History
Received: 22 February 2024
Accepted: 23 June 2025
First Online: 1 July 2025
Declarations
:
: The authors declare no conflict of interest.
: This article does not include any studies with human participants or animals performed by any of the authors.
: Dr. Patel reports grants from MicuRx Pharmaceuticals and BIOFIRE. Dr. Patel is a consultant to PhAST, Day Zero Diagnostics, DEEPULL DIAGNOSTICS, S.L., HealthTrackRx and CARB-X. In addition, Dr. Patel has a patent on Bordetella pertussis/parapertussis PCR issued, a patent on a device/method for sonication with royalties paid by Samsung to Mayo Clinic, and a patent on an anti-biofilm substance issued. Dr. Patel receives honoraria from Up-to-Date and the Infectious Diseases Board Review Course. WC, JRF, JMS and AV are employees at Adaptive Phage Therapeutics, Inc.